— Cintas Corporation (NASDAQ: CTAS) reported its third-quarter 2020 adjusted earnings of $2.16 per share versus $2.02 per share expected.
— Revenue rose by 8% to $1.81 billion versus $1.8 billion expected. The organic revenue growth rate, which adjusts for the impacts of acquisitions, foreign currency exchange rate fluctuations, and workdays difference, was 5.7%.
— The Uniform Rental and Facility Services segment registered a 4.8% organic sales growth, while First Aid and Safety Services recorded a 12.5% gain.
— Gross margin grew to 45.5% from 44.9% in the previous year quarter.
— Uniform Rental and Facility Services segment gross margin improved 90 basis points, while other gross margin declined 50 basis points.
— Due to the uncertainty, including the severity and duration of the pandemic, the company is not providing guidance for the fourth quarter of fiscal 2020 at this time and withdrawing its full fiscal year guidance.
— Although visibility to near-term financial results is currently diminished, the company remains focused on the safety and well-being of its employee-partners and the care of its customers.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
